Pancreatic beta cell proliferation and regeneration pathways

Pancreatic beta cell proliferation and regeneration pathways represent the collective molecular mechanisms responsible for the growth and renewal of insulin-producing cells within the islets of Langerhans. These pathways are of critical therapeutic interest because a significant loss of functional beta-cell mass is the underlying cause of both Type 1 and Type 2 diabetes (PubMed: 28434944). Key regulatory nodes include the DYRK1A kinase, which maintains beta cells in a quiescent state, and the Wnt, PI3K/Akt, and MAPK signaling cascades that drive the cell cycle (PubMed: 25751204). Pharmacological interventions, such as DYRK1A inhibitors like harmine or GLP-1 receptor agonists, aim to restore endogenous insulin production by stimulating the replication of existing beta cells or inducing the formation of new ones from progenitor sources (NIH: NBK554450). However, this field faces significant challenges, particularly regarding the specificity of these mitogenic signals to beta cells to avoid the risk of tumorigenesis in other tissues. Furthermore, ensuring that regenerated cells maintain their identity and glucose-responsive insulin secretion is essential for clinical efficacy. As such, these pathways are considered a broad biological process rather than a single molecular target, requiring highly precise modulation for safe therapeutic application (PubMed: 22995863).

Other names

Beta-cell regenerationBeta-cell mass expansionIslet cell proliferationBeta-cell neogenesisEndocrine pancreas regeneration

Drugs targeting these pathways typically act by inhibiting cell cycle brakes such as Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) and Glycogen synthase kinase 3 beta (GSK3B), or by activating mitogenic signaling through the Glucagon-like peptide 1 receptor (GLP-1R) and the Wnt/beta-catenin pathway (PubMed: 25751204, NIH: NBK554450). Some agents also promote the transdifferentiation of alpha cells into beta cells or stimulate the neogenesis of beta cells from ductal or acinar progenitors (PubMed: 27914512).